Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

P-Rex1 cooperates with PDGFRβ to drive cellular migration in 3D microenvironments.

Campbell AD, Lawn S, McGarry LC, Welch HC, Ozanne BW, Norman JC.

PLoS One. 2013;8(1):e53982. doi: 10.1371/journal.pone.0053982. Epub 2013 Jan 30.

2.

Analysis of the CD23-αv integrin interaction: a study with model peptides.

Edkins AL, Borland G, Kelly SM, Cogdell RJ, Ozanne BW, Cushley W.

Biochem Biophys Res Commun. 2012 Jun 1;422(2):207-12. doi: 10.1016/j.bbrc.2012.04.076. Epub 2012 Apr 27.

PMID:
22560905
3.

Differential regulation of monocyte cytokine release by αV and β(2) integrins that bind CD23.

Edkins AL, Borland G, Acharya M, Cogdell RJ, Ozanne BW, Cushley W.

Immunology. 2012 Jun;136(2):241-51. doi: 10.1111/j.1365-2567.2012.03576.x.

4.

P-Rex1 is required for efficient melanoblast migration and melanoma metastasis.

Lindsay CR, Lawn S, Campbell AD, Faller WJ, Rambow F, Mort RL, Timpson P, Li A, Cammareri P, Ridgway RA, Morton JP, Doyle B, Hegarty S, Rafferty M, Murphy IG, McDermott EW, Sheahan K, Pedone K, Finn AJ, Groben PA, Thomas NE, Hao H, Carson C, Norman JC, Machesky LM, Gallagher WM, Jackson IJ, Van Kempen L, Beermann F, Der C, Larue L, Welch HC, Ozanne BW, Sansom OJ.

Nat Commun. 2011 Nov 22;2:555. doi: 10.1038/ncomms1560.

5.

BTB-Kelch protein Krp1 regulates proliferation and differentiation of myoblasts.

Paxton CW, Cosgrove RA, Drozd AC, Wiggins EL, Woodhouse S, Watson RA, Spence HJ, Ozanne BW, Pell JM.

Am J Physiol Cell Physiol. 2011 Jun;300(6):C1345-55. doi: 10.1152/ajpcell.00321.2010. Epub 2011 Mar 2.

6.

CD23/FcεRII: molecular multi-tasking.

Acharya M, Borland G, Edkins AL, Maclellan LM, Matheson J, Ozanne BW, Cushley W.

Clin Exp Immunol. 2010 Oct;162(1):12-23. doi: 10.1111/j.1365-2249.2010.04210.x. Review.

7.

Spectral clustering of microarray data elucidates the roles of microenvironment remodeling and immune responses in survival of head and neck squamous cell carcinoma.

Thurlow JK, Peña Murillo CL, Hunter KD, Buffa FM, Patiar S, Betts G, West CM, Harris AL, Parkinson EK, Harrison PR, Ozanne BW, Partridge M, Kalna G.

J Clin Oncol. 2010 Jun 10;28(17):2881-8. doi: 10.1200/JCO.2009.24.8724. Epub 2010 May 10. Erratum in: J Clin Oncol. 2010 Oct 20;28(30):4664.

PMID:
20458058
8.

Novel beta-propeller of the BTB-Kelch protein Krp1 provides a binding site for Lasp-1 that is necessary for pseudopodial extension.

Gray CH, McGarry LC, Spence HJ, Riboldi-Tunnicliffe A, Ozanne BW.

J Biol Chem. 2009 Oct 30;284(44):30498-507. doi: 10.1074/jbc.M109.023259. Epub 2009 Sep 2.

9.

SDF-1 and PDGF enhance alphavbeta5-mediated ERK activation and adhesion-independent growth of human pre-B cell lines.

Acharya M, Edkins AL, Ozanne BW, Cushley W.

Leukemia. 2009 Oct;23(10):1807-17. doi: 10.1038/leu.2009.126. Epub 2009 Jul 16.

PMID:
19609283
10.

TGF-beta-mediated activation of RhoA signalling is required for efficient (V12)HaRas and (V600E)BRAF transformation.

Fleming YM, Ferguson GJ, Spender LC, Larsson J, Karlsson S, Ozanne BW, Grosse R, Inman GJ.

Oncogene. 2009 Feb 19;28(7):983-93. doi: 10.1038/onc.2008.449. Epub 2008 Dec 15.

PMID:
19079344
11.

Rab25 associates with alpha5beta1 integrin to promote invasive migration in 3D microenvironments.

Caswell PT, Spence HJ, Parsons M, White DP, Clark K, Cheng KW, Mills GB, Humphries MJ, Messent AJ, Anderson KI, McCaffrey MW, Ozanne BW, Norman JC.

Dev Cell. 2007 Oct;13(4):496-510.

12.

alphavbeta5 integrin sustains growth of human pre-B cells through an RGD-independent interaction with a basic domain of the CD23 protein.

Borland G, Edkins AL, Acharya M, Matheson J, White LJ, Allen JM, Bonnefoy JY, Ozanne BW, Cushley W.

J Biol Chem. 2007 Sep 14;282(37):27315-26. Epub 2007 May 31.

13.

p120-catenin is required for the collective invasion of squamous cell carcinoma cells via a phosphorylation-independent mechanism.

Macpherson IR, Hooper S, Serrels A, McGarry L, Ozanne BW, Harrington K, Frame MC, Sahai E, Brunton VG.

Oncogene. 2007 Aug 9;26(36):5214-28. Epub 2007 Mar 5.

PMID:
17334396
14.

Low expression of HER2 protein in breast cancer is biologically significant.

Tovey SM, Reeves JR, Stanton P, Ozanne BW, Bartlett JM, Cooke TG.

J Pathol. 2006 Nov;210(3):358-62.

PMID:
16981252
15.

Transcription factors control invasion: AP-1 the first among equals.

Ozanne BW, Spence HJ, McGarry LC, Hennigan RF.

Oncogene. 2007 Jan 4;26(1):1-10. Epub 2006 Jun 26. Review.

PMID:
16799638
16.

Calpain 2 and Src dependence distinguishes mesenchymal and amoeboid modes of tumour cell invasion: a link to integrin function.

Carragher NO, Walker SM, Scott Carragher LA, Harris F, Sawyer TK, Brunton VG, Ozanne BW, Frame MC.

Oncogene. 2006 Sep 21;25(42):5726-40. Epub 2006 May 1.

PMID:
16652152
17.

AP-1 differentially expressed proteins Krp1 and fibronectin cooperatively enhance Rho-ROCK-independent mesenchymal invasion by altering the function, localization, and activity of nondifferentially expressed proteins.

Spence HJ, McGarry L, Chew CS, Carragher NO, Scott-Carragher LA, Yuan Z, Croft DR, Olson MF, Frame M, Ozanne BW.

Mol Cell Biol. 2006 Feb;26(4):1480-95.

18.

Invasion is a genetic program regulated by transcription factors.

Ozanne BW, Spence HJ, McGarry LC, Hennigan RF.

Curr Opin Genet Dev. 2006 Feb;16(1):65-70. Epub 2005 Dec 27. Review.

PMID:
16377173
19.

Role of Mayven, a kelch-related protein in oligodendrocyte process formation.

Williams SK, Spence HJ, Rodgers RR, Ozanne BW, Fitzgerald U, Barnett SC.

J Neurosci Res. 2005 Sep 1;81(5):622-31.

PMID:
16035103
20.
21.

Invasion of normal human fibroblasts induced by v-Fos is independent of proliferation, immortalization, and the tumor suppressors p16INK4a and p53.

Scott LA, Vass JK, Parkinson EK, Gillespie DA, Winnie JN, Ozanne BW.

Mol Cell Biol. 2004 Feb;24(4):1540-59.

23.
24.

Regulation of a multigenic invasion programme by the transcription factor, AP-1: re-expression of a down-regulated gene, TSC-36, inhibits invasion.

Johnston IM, Spence HJ, Winnie JN, McGarry L, Vass JK, Meagher L, Stapleton G, Ozanne BW.

Oncogene. 2000 Nov 9;19(47):5348-58.

25.

Transcriptional regulation of cell invasion: AP-1 regulation of a multigenic invasion programme.

Ozanne BW, McGarry L, Spence HJ, Johnston I, Winnie J, Meagher L, Stapleton G.

Eur J Cancer. 2000 Aug;36(13 Spec No):1640-8. Review.

PMID:
10959050
26.

A functional role for interleukin (IL)-4-driven cyclic amp accumulation in human b lymphocytes.

McKay CE, Hewitt EL, Ozanne BW, Cushley W.

Cytokine. 2000 Jun;12(6):731-6.

PMID:
10843754
27.

Krp1, a novel kelch related protein that is involved in pseudopod elongation in transformed cells.

Spence HJ, Johnston I, Ewart K, Buchanan SJ, Fitzgerald U, Ozanne BW.

Oncogene. 2000 Mar 2;19(10):1266-76.

28.

The transcription factor AP-1 is required for EGF-induced activation of rho-like GTPases, cytoskeletal rearrangements, motility, and in vitro invasion of A431 cells.

Malliri A, Symons M, Hennigan RF, Hurlstone AF, Lamb RF, Wheeler T, Ozanne BW.

J Cell Biol. 1998 Nov 16;143(4):1087-99.

29.
30.

Essential functions of ezrin in maintenance of cell shape and lamellipodial extension in normal and transformed fibroblasts.

Lamb RF, Ozanne BW, Roy C, McGarry L, Stipp C, Mangeat P, Jay DG.

Curr Biol. 1997 Sep 1;7(9):682-8.

31.

Inhibition of apoptosis in a human pre-B-cell line by CD23 is mediated via a novel receptor.

White LJ, Ozanne BW, Graber P, Aubry JP, Bonnefoy JY, Cushley W.

Blood. 1997 Jul 1;90(1):234-43.

32.

AP-1-mediated invasion requires increased expression of the hyaluronan receptor CD44.

Lamb RF, Hennigan RF, Turnbull K, Katsanakis KD, MacKenzie ED, Birnie GD, Ozanne BW.

Mol Cell Biol. 1997 Feb;17(2):963-76.

33.
34.

Quantitative radioimmunohistochemical measurements of p185(erbB-2) in frozen tissue sections.

Reeves JR, Going JJ, Smith G, Cooke TG, Ozanne BW, Stanton PD.

J Histochem Cytochem. 1996 Nov;44(11):1251-9.

PMID:
8918900
35.

Quantitative estimation of epidermal growth factor receptor and c-erbB-2 in human breast cancer.

Robertson KW, Reeves JR, Smith G, Keith WN, Ozanne BW, Cooke TG, Stanton PD.

Cancer Res. 1996 Aug 15;56(16):3823-30.

36.
37.

Soluble CD40 ligand induces expression of CD25 and CD23 in resting human tonsillar B lymphocytes.

Burlinson EL, Graber P, Bonnefoy JY, Ozanne BW, Cushley W.

Eur J Immunol. 1996 May;26(5):1069-73.

PMID:
8647169
38.
39.

Anti-immunoglobulin and anti-CD40 stimulation induces CD25 expression by resting human tonsillar B lymphocytes.

Burlinson EL, Pringle HM, Ozanne BW, Cushley W.

Immunol Lett. 1995 Feb;45(1-2):93-8.

PMID:
7542628
40.

Fos-transformation activates genes associated with invasion.

Hennigan RF, Hawker KL, Ozanne BW.

Oncogene. 1994 Dec;9(12):3591-600.

PMID:
7970719
41.

Localization of EGF receptors in frozen tissue sections by antibody and biotinylated EGF-based techniques.

Reeves JR, Cooke TG, Fenton-Lee D, McNicol AM, Ozanne BW, Richards RC, Walsh A.

J Histochem Cytochem. 1994 Mar;42(3):307-14.

PMID:
8308248
42.

Transformation by the fos or jun oncogene does not increase AP-1 DNA-binding activity.

Hawker KL, Pintzas A, Hennigan RF, Gillespie DA, Ozanne BW.

J Virol. 1993 Sep;67(9):5487-95.

43.

Multistage progression of Abelson virus-infected murine pre-B-cells to the tumorigenic state.

Palumbo GJ, Ozanne BW, Kettman JR.

Cancer Res. 1990 Mar 15;50(6):1917-23.

44.

Supplemental Content

Loading ...
Support Center